Alterola Biotech Inc (OTCMKTS:ALTA) Director Jr. Fred W. Fairclough sold 3,750 shares of Alterola Biotech stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $20.26, for a total transaction of $75,975.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Alterola Biotech stock opened at $18.75 on Friday. The business has a 50-day moving average price of $12.70. Alterola Biotech Inc has a 12-month low of $13.55 and a 12-month high of $31.27.
Alterola Biotech (OTCMKTS:ALTA) last released its earnings results on Wednesday, July 29th. The company reported $0.55 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.47 by $0.08. The firm had revenue of $31.91 million during the quarter, compared to the consensus estimate of $30.39 million.
Alterola Biotech Company Profile
Alterola Biotech, Inc, a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums.
Receive News & Ratings for Alterola Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterola Biotech and related companies with MarketBeat.com's FREE daily email newsletter.